Adenomyosis Treatment Market Outlook Report Shows How Top Companies Is Able to Survive in Future Till 2030
Adenomyosis
is defined as a medical condition in which the inner lining of the uterus (also
known as the endometrium) breaks through the muscle wall of the uterus (the
myometrium). The treatment of this medical problem is called adenomyosis.
The Adenomyosis Treatment Market is anticipated to reach USD 426.6
Million by 2030 at 6.2% CAGR during the forecast period 2022-2030.
The biggest
driver for the global adenomyosis treatment market growth is the global prevalence
of adenomyosis. The increasing awareness about adenomyosis as well as its
treatment is boosting the global adenomyosis treatment market by creating the
demand, supply, and sales for new drugs and therapies, along with advanced
medical technology-focused towards the adenomyosis. Hence, new opportunities
are arising for market growth. During the forecast period, increased funding
for research & development (R&D) to develop more advanced products (medical
devices) is expected to reflect favorably on the market. However, the market in
developing countries can face hurdles as many people are not aware of this
medical problem.
Market Segmentation
The global
adenomyosis treatment market segmentation encompasses diagnosis, type, and
treatment. MRFR’s take on the market marks various facets of the market
in-depth.
The
diagnosis-based segmentation of this market covers endometrial biopsy, magnetic resonance
imaging (MRI), ultrasound, and others. The ultrasound segment has been
sub-segmented into transabdominal ultrasound and endovaginal ultrasound which
is also known as transvaginal ultrasound.
By type, the market includes adenomyoma,
diffuse, focal, and others.
By
treatment, the
market covers anti-inflammatory drugs, hormone medications, and hysterectomy.
The anti-inflammatory drugs segment has been sub-segmented into Advil,
ibuprofen, Motrin ibuprofen (Motrin IB), and others. The hormone medications
segment has been sub-segmented into aromatase inhibitors and
Gonadotropin-releasing hormone (GnRH) agonists. The hysterectomy segment
radical hysterectomy, supracervical hysterectomy (also known as a subtotal
hysterectomy), and total hysterectomy.
Key Players
Big players
in the global Adenomyosis Treatment Market Players are Bayer AG (Germany), Ferring
B.V. (Switzerland), Johnson & Johnson Consumer Inc. (USA), Merck KGaA
(Germany), Novartis (Switzerland), Pfizer Inc. (USA) and Speciality European
Pharma (UK).
Regional Segmentation
A
geographical outlining of the global adenomyosis treatment market covers the
Americas (North America & South America), Asia Pacific, Europe, and the
Middle East & Africa (MEA).
The Americas
is the biggest regional market as North America alone has the potential of
becoming a powerful regional market. Due to the advanced medical facilities
being available in the USA North America is a larger regional market segment
compared to South America. North America is the largest regional market segment
due to the rapid adoption of new drugs and therapies. Continuous innovation on
the technological front and heavy use of technology in the medical sector boost
market in this region. USA and Canada are generating the maximum revenue in
this region.
Europe is
the second-largest regional market as many important market players are based
in Europe. Due to the reasons the same as in The Americas, Western Europe is a
bigger market compared to Eastern Europe. The major market share comes from
France, Germany, Spain, Italy, and the UK.
The Asia
Pacific region is an important regional market due to improving medical sector
and stable technological progress. In this report, this regional market has
been segmented into Asia and the Pacific. In Asia, the key country-specific
markets are China, India, Japan, and South Korea. An observation of the
remaining countries in Asia and the Pacific region featured in this report
calculates the additional market revenue from some other countries.
In the MEA
region, the market has been slow due to limited availability of advanced
medical facilities. Countries focused in the report include Egypt, Saudi
Arabia, and the UAE.
Latest Industry News
·
A
new MRI-based therapeutic technique uses ultrasonic pulses to ablate the target
tissue. Using MRI thermal imaging system, it continuously measures the
temperature changes inside the body to pinpoint and guide the treatment. It is
useful for the treatment of adenomyosis, facetal arthropathy, and bone tumors (both
benign and malignant) for pain relief. 9 APR 2019
Related Report-
Process
Analytical Technology (PAT) Market Research Report- Global Forecast To 2027
Global
Anti Asthma Drugs Market – Forecast to 2027
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013

Comments
Post a Comment